Surgery Linked to Slight Cognitive Decline in Older Adults

The increasing life expectancy has led to a greater number of older adults undergoing surgical procedures for various conditions, from orthopaedic repairs to cardiovascular interventions. While the immediate risks of surgery, such as infection, haemorrhage, and cardiac events, are well-documented, the long-term cognitive impact has received growing attention. Postoperative cognitive dysfunction (POCD) is a recognised complication, distinct from delirium, characterised by a decline in memory, executive function, and processing speed that can persist for months or even years after surgery.¹

The underlying mechanisms are complex and likely multifactorial, involving systemic inflammation, neuroinflammation, anaesthetic agents, and cerebrovascular changes.² Older age, pre-existing cognitive impairment, and the type and duration of surgery are identified risk factors.³ The prevalence of POCD varies significantly across studies, largely due to differences in diagnostic criteria, follow-up duration, and patient populations. However, it represents a substantial clinical challenge, impacting patient quality of life, functional independence, and healthcare resource utilization. Understanding the epidemiology and risk factors is crucial for developing effective preventative and therapeutic strategies.

What the studies show

Multiple observational studies and meta-analyses have examined the relationship between surgery and cognitive outcomes in older adults. These studies typically compare cognitive performance before surgery to performance at various time points post-surgery, often using standardised neuropsychological test batteries. A consistent pattern emerges, indicating a small but measurable decline in cognitive function following surgery in a subset of older patients.⁴

For instance, a longitudinal study tracking cognitive trajectories in older adults found that those who underwent major non-cardiac surgery experienced a decline in global cognitive scores equivalent to an additional 0.1 to 0.2 standard deviations compared to non-surgical controls over a 12-month period.⁵ This decline was observed across multiple cognitive domains, including memory, executive function, and processing speed. While the magnitude of this decline may appear modest, it can be clinically relevant for individuals already at risk of cognitive impairment or those with high cognitive demands.⁶ The methodology often involves baseline cognitive assessments several weeks or months prior to surgery to establish a stable cognitive profile, followed by repeat assessments at intervals such as 1 week, 3 months, and 12 months post-surgery. Control groups typically consist of age-matched individuals who do not undergo surgery but are followed over similar timeframes, or patients undergoing minor surgical procedures. This approach helps to differentiate surgery-specific cognitive changes from age-related cognitive decline or the effects of underlying medical conditions.

Another large cohort study, involving over 1,000 participants aged 65 and older, reported that approximately 10% to 15% of patients experienced a significant decline in at least one cognitive domain at three months post-surgery, which persisted in about 5% to 10% at one year.⁷ The risk was particularly elevated for patients undergoing procedures with longer anaesthesia times or those experiencing postoperative complications such as delirium or infection.⁸ These findings underscore the importance of identifying vulnerable patient populations, such as those with pre-existing mild cognitive impairment or a history of stroke, who may be at higher risk for more pronounced or persistent cognitive deficits after surgery. The type of surgery also plays a role, with major abdominal, orthopaedic, and cardiac surgeries often associated with a higher incidence of POCD compared to less invasive procedures.

The specific anaesthetic agents used have also been investigated, though no single agent has been definitively identified as solely responsible for POCD. Both volatile anaesthetics and intravenous agents have been implicated in preclinical models, suggesting a broader effect of anaesthesia on neuronal function and inflammatory pathways.⁹ However, human studies have not consistently demonstrated a clear advantage of one anaesthetic technique over another in preventing long-term cognitive decline.¹⁰ The mechanisms by which anaesthetics might contribute to POCD include direct neurotoxicity, modulation of neurotransmitter systems, and potentiation of inflammatory responses. The interaction between anaesthetic exposure and the surgical stress response, which itself can induce systemic inflammation, is a key area of ongoing research.

Limitations of existing research include heterogeneity in study designs, cognitive assessment tools, and definitions of POCD. Many studies are observational, making it challenging to establish definitive causality and control for all confounding factors, such as the underlying medical conditions necessitating surgery. Furthermore, the clinical significance of a small statistical decline in cognitive scores can be difficult to interpret for individual patients. The lack of a universally accepted definition for POCD and standardized diagnostic criteria complicates comparisons across studies and the interpretation of prevalence rates. Future research needs to focus on identifying specific biomarkers for POCD, developing targeted interventions, and conducting large-scale randomised controlled trials to evaluate strategies for mitigating this risk.¹¹ These strategies could include optimizing perioperative care, implementing enhanced recovery protocols, and exploring pharmacological or non-pharmacological interventions aimed at reducing inflammation or supporting neuronal health.